| UniProt ID | APC10_HUMAN | |
|---|---|---|
| UniProt AC | Q9UM13 | |
| Protein Name | Anaphase-promoting complex subunit 10 | |
| Gene Name | ANAPC10 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 185 | |
| Subcellular Localization | ||
| Protein Description | Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains.. | |
| Protein Sequence | MTTPNKTPPGADPKQLERTGTVREIGSQAVWSLSSCKPGFGVDQLRDDNLETYWQSDGSQPHLVNIQFRRKTTVKTLCIYADYKSDESYTPSKISVRVGNNFHNLQEIRQLELVEPSGWIHVPLTDNHKKPTRTFMIQIAVLANHQNGRDTHMRQIKIYTPVEESSIGKFPRCTTIDFMMYRSIR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MTTPNKTPP ------CCCCCCCCC | 51.46 | 22199227 | |
| 2 | Acetylation | ------MTTPNKTPP ------CCCCCCCCC | 51.46 | 22814378 | |
| 3 | Phosphorylation | -----MTTPNKTPPG -----CCCCCCCCCC | 24.46 | 25850435 | |
| 6 | Ubiquitination | --MTTPNKTPPGADP --CCCCCCCCCCCCH | 64.71 | 21906983 | |
| 7 | Phosphorylation | -MTTPNKTPPGADPK -CCCCCCCCCCCCHH | 41.16 | 22199227 | |
| 14 | Ubiquitination | TPPGADPKQLERTGT CCCCCCHHHHCCCEE | 68.97 | 22817900 | |
| 17 | Ubiquitination | GADPKQLERTGTVRE CCCHHHHCCCEEEEE | 45.78 | 21890473 | |
| 25 | Ubiquitination | RTGTVREIGSQAVWS CCEEEEEEHHHHEEE | 4.51 | 21890473 | |
| 40 | Ubiquitination | LSSCKPGFGVDQLRD CCCCCCCCCCHHHCC | 13.46 | 21890473 | |
| 44 | Ubiquitination | KPGFGVDQLRDDNLE CCCCCCHHHCCCCCC | 35.67 | 21890473 | |
| 48 | Ubiquitination | GVDQLRDDNLETYWQ CCHHHCCCCCCEEEE | 56.00 | 21890473 | |
| 52 | Ubiquitination | LRDDNLETYWQSDGS HCCCCCCEEEECCCC | 32.97 | 21890473 | |
| 71 | Acetylation | VNIQFRRKTTVKTLC EEEEEECCCEEEEEE | 44.27 | 20167786 | |
| 72 | Phosphorylation | NIQFRRKTTVKTLCI EEEEECCCEEEEEEE | 34.70 | 26074081 | |
| 73 | Phosphorylation | IQFRRKTTVKTLCIY EEEECCCEEEEEEEE | 24.04 | 26074081 | |
| 76 | Phosphorylation | RRKTTVKTLCIYADY ECCCEEEEEEEEEEC | 23.64 | 26074081 | |
| 80 | Phosphorylation | TVKTLCIYADYKSDE EEEEEEEEEECCCCC | 7.76 | 22817900 | |
| 82 | Acetylation | KTLCIYADYKSDESY EEEEEEEECCCCCCC | 34.13 | - | |
| 83 | Phosphorylation | TLCIYADYKSDESYT EEEEEEECCCCCCCC | 12.29 | 22817900 | |
| 88 | Phosphorylation | ADYKSDESYTPSKIS EECCCCCCCCCCEEE | 39.02 | 30631047 | |
| 89 | Phosphorylation | DYKSDESYTPSKISV ECCCCCCCCCCEEEE | 22.18 | 27461979 | |
| 90 | Phosphorylation | YKSDESYTPSKISVR CCCCCCCCCCEEEEE | 30.30 | 30576142 | |
| 92 | Phosphorylation | SDESYTPSKISVRVG CCCCCCCCEEEEEEC | 34.52 | 30631047 | |
| 93 | Ubiquitination | DESYTPSKISVRVGN CCCCCCCEEEEEECC | 39.96 | 21906983 | |
| 104 | Ubiquitination | RVGNNFHNLQEIRQL EECCCCCCHHHEEEE | 39.00 | 22817900 | |
| 127 | Ubiquitination | IHVPLTDNHKKPTRT EEEECCCCCCCCCEE | 43.58 | 22817900 | |
| 131 | Ubiquitination | LTDNHKKPTRTFMIQ CCCCCCCCCEEEEEE | 31.73 | 22817900 | |
| 160 | Phosphorylation | MRQIKIYTPVEESSI EEEEEEECCCCHHCC | 25.08 | - | |
| 165 | Phosphorylation | IYTPVEESSIGKFPR EECCCCHHCCCCCCC | 17.47 | 24719451 | |
| 169 | Ubiquitination | VEESSIGKFPRCTTI CCHHCCCCCCCCCEE | 50.99 | 22817900 | |
| 169 | Acetylation | VEESSIGKFPRCTTI CCHHCCCCCCCCCEE | 50.99 | 19608861 | |
| 175 | Phosphorylation | GKFPRCTTIDFMMYR CCCCCCCEEEEEEEE | 23.36 | - | |
| 180 | Acetylation | CTTIDFMMYRSIR-- CCEEEEEEEECCC-- | 2.25 | 19608861 | |
| 180 | Ubiquitination | CTTIDFMMYRSIR-- CCEEEEEEEECCC-- | 2.25 | 21890473 | |
| 181 | Phosphorylation | TTIDFMMYRSIR--- CEEEEEEEECCC--- | 6.88 | - | |
| 203 | Ubiquitination | ------------------------- ------------------------- | 21890473 | ||
| 207 | Ubiquitination | ----------------------------- ----------------------------- | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of APC10_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of APC10_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of APC10_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SMAD2_HUMAN | SMAD2 | physical | 15144564 | |
| SMAD3_HUMAN | SMAD3 | physical | 15144564 | |
| CDC27_HUMAN | CDC27 | physical | 10498862 | |
| CDC16_HUMAN | CDC16 | physical | 10498862 | |
| CDC23_HUMAN | CDC23 | physical | 22939629 | |
| CDC16_HUMAN | CDC16 | physical | 22939629 | |
| APC1_HUMAN | ANAPC1 | physical | 22939629 | |
| CDC27_HUMAN | CDC27 | physical | 22939629 | |
| APC4_HUMAN | ANAPC4 | physical | 22939629 | |
| APC7_HUMAN | ANAPC7 | physical | 22939629 | |
| ANC2_HUMAN | ANAPC2 | physical | 26344197 | |
| APC7_HUMAN | ANAPC7 | physical | 26344197 | |
| CDC26_HUMAN | CDC26 | physical | 26344197 | |
| NP1L4_HUMAN | NAP1L4 | physical | 26344197 | |
| TAF3_HUMAN | TAF3 | physical | 26344197 | |
| UTP15_HUMAN | UTP15 | physical | 26344197 | |
| NUP98_HUMAN | NUP98 | physical | 27097363 | |
| HXD13_HUMAN | HOXD13 | physical | 27097363 | |
| LNP1_HUMAN | LNP1 | physical | 27097363 | |
| HHEX_HUMAN | HHEX | physical | 27097363 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-169, AND MASS SPECTROMETRY. | |